Pioglitazone was associated with a lower risk of developing skin ulcers in patients with Werner disease in a Japanese study, ...

Objective: Published reports suggest that pioglitazone and rosiglitazone have different effects on lipids in patients with type 2 diabetes. However, these previous studies were either ...

Background: Sodium-glucose co-transporter-2 inhibitors (SGLT2i) have cardiovascular (CV) benefits, particularly in reducing the risk of heart failure (HF). Pioglitazone (Pio) has shown potential in ...

Akums combines two potent diabetes medicines for enhanced treatment efficacy: Our Bureau, Bengaluru Tuesday, February 4, 2025, 15:30 Hrs [IST] Akums Drugs and Pharmaceuticals, a l ...

The research suggests that pioglitazone's ability to reduce inflammation helps wounds heal faster and prevents ulcers from forming. However, since the drug can cause side effects, like weaker ...

SGLT2 inhibitors confer greater risk reductions for major adverse cardiovascular events in older adults with type 2 diabetes compared with younger adults, according to findings from a systematic ...

There are two drugs in this class: pioglitazone (Actos) and rosiglitazone (Avandia), and both were approved by the FDA in 1999. A third drug in this class, troglitazone (Rezulin), was approved in ...

Anti-inflammatory drugs were linked to a reduced risk of dementia. Antibiotics, antivirals and vaccines, such as for ...

Anti-inflammatory drugs were linked to a reduced risk of dementia. Antibiotics, antivirals and vaccines, such as for ...